• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON, S.A. BD PHASEAL¿ PROTECTOR P55; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON, S.A. BD PHASEAL¿ PROTECTOR P55; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Model Number 515117
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 06/05/2023
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
H.3.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event or Problem Description
It was reported that during use with bd phaseal¿ protector p55 the spike was discovered to be broken when attempting to attach to vial.This affected 13 devices.The following information was provided by the initial reporter, translated from japanese to english: this report is about phaseal protector p55.During the preparation of treakisym, the spike was found broken when attempting to attach the product (p55) to the vial.
 
Event or Problem Description
It was reported that during use with bd phaseal¿ protector p55 the spike was discovered to be broken when attempting to attach to vial.This affected 13 devices.The following information was provided by the initial reporter, translated from japanese to english: this report is about phaseal protector p55.During the preparation of treakisym, the spike was found broken when attempting to attach the product (p55) to the vial.
 
Additional Manufacturer Narrative
H6: investigation summary fourteen samples were provided to our quality team for investigation.Through visual inspection, the tip of the protector spikes are observed to be bent, verifying the reported incident.A device history review was performed for the reported lot 2204113, no deviations or non-conformances were identified during the manufacturing process that could have contributed to this incident.Five retained samples of the same lot were used for additional evaluation.No damage to the protector spikes was observed.Final products in this manufacturing line, for this reference are sampled and they are subjected to visual and functional inspections during the different manufacturing sub-processes according to procedures.While we could not identify a direct issue, it was determined the damage likely occurred during the assembly process when the piece moved between machines.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD PHASEAL¿ PROTECTOR P55
Common Device Name
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
BECTON DICKINSON, S.A.
camino de valdeolivia
s/n
san agustin de guadalix
Manufacturer (Section G)
BECTON DICKINSON, S.A.
camino de valdeolivia
s/n
san agustin de guadalix
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8448235433
MDR Report Key17215953
Report Number3003152976-2023-00256
Device Sequence Number14206020
Product Code ONB
UDI-Device Identifier00382905151170
UDI-Public(01)00382905151170
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K130197
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,Foreign,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 06/28/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Model Number515117
Device Catalogue Number515117
Device Lot Number2204113
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/12/2023
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/05/2023
Supplement Date Received by Manufacturer06/28/2023
Initial Report FDA Received Date06/28/2023
Supplement Report FDA Received Date07/14/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured04/22/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-